Страна: Австралия
Език: английски
Източник: Department of Health (Therapeutic Goods Administration)
clopidogrel hydrogen sulfate, Quantity: 97.9 mg (Equivalent: clopidogrel, Qty 75 mg)
Alphapharm Pty Ltd
clopidogrel hydrogen sulfate
Tablet, film coated
Excipient Ingredients: colloidal anhydrous silica; lactose; microcrystalline cellulose; magnesium stearate; croscarmellose sodium; sodium lauryl sulfate; titanium dioxide; hypromellose; macrogol 8000; polydextrose; macrogol 400
Oral
7, 4, 56, 28, 14, 84, 280, 50, 112
(S4) Prescription Only Medicine
Prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease. Acute Coronary Syndrome: Piax is indicated in combination with aspirin for patients with:- Unstable angina or non-ST-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). Piax is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularisation (surgical or PCI, with or without stent). -ST-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. In this population, Piax has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy.
Visual Identification: A white film-coated, round, biconvex, beveled edge tablet debossed with "M" on one side of the tablet and "C27" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2010-05-21
PIAX _clopidogrel (as hydrogen sulfate)_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Piax. It does not contain all the available information. Some of the information it contains may not apply to you. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the risks of you taking Piax against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, TALK TO YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT PIAX IS USED FOR PIAX contains the medicine clopidogrel. Clopidogrel belongs to a group of medicines known as antiplatelet medicines. Platelets are very small blood cells which clump together during blood clotting. By preventing this clumping, antiplatelet medicines reduce the chances of blood clots forming (a process called thrombosis). Piax is used to prevent blood clots forming in hardened blood vessels as they can lead to events such as stroke, heart attack or death. You have been prescribed Piax to help prevent blood clots forming and to reduce the risk of stroke, heart attack and death because • YOU HAVE PREVIOUSLY SUFFERED A HEART ATTACK, STROKE OR HAVE A CONDITION KNOWN AS PERIPHERAL ARTERIAL DISEASE (LEG PAIN ON WALKING OR AT REST) • YOU HAVE SUFFERED ACUTE CORONARY SYNDROME (EITHER A SEVERE TYPE OF CHEST PAIN CALLED UNSTABLE ANGINA, OR A HEART ATTACK). IN THIS CASE YOU MAY ALSO BE PRESCRIBED ASPIRIN. Your doctor may have prescribed this medicine for another use. If you want more information, ask your doctor. Piax is only available on a doctor's prescription. BEFORE YOU TAKE PIAX _WHEN YOU MUST NOT TAKE IT_ Do not take Piax if: • you are allergic to any medicine containing clopidogrel • you are allergic to any of the ingredients listed at the end of this leaflet Some of the symptoms of an allergic reaction may include shortness of breath, wheezing or difficulty breathing, Прочетете целия документ
AUSTRALIAN PRODUCT INFORMATION PIAX _Clopidogrel (as hydrogen sulfate) film coated tablets _ 1 NAME OF THE MEDICINE Clopidogrel hydrogen sulfate 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film coated tablet contains 75 mg of clopidogrel (as hydrogen sulfate) as the active ingredient. Excipients with known effect: Sugars (as lactose) and trace quantities of galactose and sulfites. For the full list of excipients, see SECTION 6.1 LIST OF EXCIPIENTS . 3 PHARMACEUTICAL FORM PIAX 75 mg film coated tablet: white, film coated, round, biconvex, beveled edge tablet, debossed with “M” on one side of the tablet and “C27” on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease. ACUTE CORONARY SYNDROME PIAX is indicated in combination with aspirin for patients with: • Unstable angina or non-ST-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). PIAX is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularisation (surgical or PCI, with or without stent). • ST-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. In this population, PIAX has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy. 4.2 DOSE AND METHOD OF ADMINISTRATION Clopidogrel should be taken once a day with or without food. ADULTS Generally, clopidogrel should be given as a single daily dose of 75 mg. In patients with acute coronary syndrome: • unstable angina or non-ST-elevation myocardial infarction - clopidogrel treatment should be initiated with a single 300 mg loading dose and then continued long-term Прочетете целия документ